Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Open AccessResearch

nuID: a universal naming scheme of oligonucleotides for Illumina, Affymetrix, and other microarrays

Pan Du email, Warren A Kibbe email and Simon M Lin email

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, 60611, USA

author email corresponding author email

Biology Direct 2007, 2:16doi:10.1186/1745-6150-2-16

Published: 31 May 2007

Abstract

Background

Oligonucleotide probes that are sequence identical may have different identifiers between manufacturers and even between different versions of the same company's microarray; and sometimes the same identifier is reused and represents a completely different oligonucleotide, resulting in ambiguity and potentially mis-identification of the genes hybridizing to that probe.

Results

We have devised a unique, non-degenerate encoding scheme that can be used as a universal representation to identify an oligonucleotide across manufacturers. We have named the encoded representation 'nuID', for nucleotide universal identifier. Inspired by the fact that the raw sequence of the oligonucleotide is the true definition of identity for a probe, the encoding algorithm uniquely and non-degenerately transforms the sequence itself into a compact identifier (a lossless compression). In addition, we added a redundancy check (checksum) to validate the integrity of the identifier. These two steps, encoding plus checksum, result in an nuID, which is a unique, non-degenerate, permanent, robust and efficient representation of the probe sequence. For commercial applications that require the sequence identity to be confidential, we have an encryption schema for nuID. We demonstrate the utility of nuIDs for the annotation of Illumina microarrays, and we believe it has universal applicability as a source-independent naming convention for oligomers.

Reviewers

This article was reviewed by Itai Yanai, Rong Chen (nominated by Mark Gerstein), and Gregory Schuler (nominated by David Lipman).


© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.